ERAS — Erasca, Inc. stock price, charts and financials

QT92Erasca, Inc.

Erasca, Inc. (NASDAQ: ERAS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
18.38
+0.54+3.03%
OverviewShort InterestFilings
ERASQT92Erasca, Inc.·NASDAQ
18.38+3.03%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 14, 20268-KCurrent report
Jul 14, 2026424B5Prospectus
Jul 13, 2026424B5Prospectus
Jul 13, 20268-KCurrent report
Jul 13, 2026S-3ASRS-3ASR
Jul 01, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 11, 20268-KCurrent report
May 11, 202610-QQuarterly report
Apr 28, 2026DEFA14AAdditional proxy soliciting materials
Apr 28, 2026ARSAnnual report to shareholders
Apr 28, 2026DEF 14ADefinitive proxy statement
Apr 27, 20268-KCurrent report
Apr 27, 20268-KCurrent report
Apr 21, 20268-KCurrent report
#1 / 25 of 284
Page
▼
/ 12